NIAGEN BIOSCIENCE, INC. Long-term Line of Credit
NIAGEN BIOSCIENCE, INC. (NAGE) had Long-term Line of Credit of $2.50 million as of 2015-10-03, per its 10-Q filed 2015-11-12.
Discontinued › Balance Sheet › Liabilities › Debt › Long-Term Debt, Unclassified
us-gaap:LineOfCredit · last filed 2016-08-11
- 2015-10-03: Long-term Line of Credit $2.50M.
- 2015-07-04: Long-term Line of Credit $2.50M.
- 2015-06-17: Long-term Line of Credit $2.50M.
- 2014-09-01: Long-term Line of Credit $2.50M.
| Period end | Long-term Line of Credit |
|---|---|
| 2015-10-03 | $2.50M 10-Q · filed 2015-11-12 |
| 2015-07-04 | $2.50M 10-Q · filed 2015-08-13 |
| 2015-06-17 | $2.50M 10-Q · filed 2016-08-11 |
| 2014-09-01 | $2.50M 10-Q · filed 2016-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |